InvestorsHub Logo
Followers 154
Posts 2653
Boards Moderated 0
Alias Born 01/29/2004

Re: frrol post# 116208

Saturday, 08/19/2017 5:17:50 PM

Saturday, August 19, 2017 5:17:50 PM

Post# of 464084
Other Agonists? Great, What Are They, Clinical Results?

Important question for potential or existing Anavex equity holders. If there are other sigma-1 receptor agonists equivalent or superior to Anavex 2-73, please post a list of them.

And, please tell of their status in testing against Alzheimer’s and other Central Nervous System diseases.

Can any of these be suppressing competitors of Anavex 2-73. If so, what might be the evidence for this? Are any in current or projected clinical trials?

What are the possibilities that these other sigma-1 receptor agonists might displace Anavex 2-73?

Their mere existence on lab benches in no way affects the validity of Anavex 2-73. They have to be clinically competitive. No evidence for such has thus far been presented.

Help us all out, please.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News